Search

Your search keyword '"M Valerio"' showing total 863 results

Search Constraints

Start Over You searched for: Author "M Valerio" Remove constraint Author: "M Valerio"
863 results on '"M Valerio"'

Search Results

52. mpMRI of the prostate in patients carrying a high clinical risk of prostate cancer diagnosis: Is this imaging test necessary for diagnostic purposes in this subset of patients?

54. Integrating index lesion volume to better classify men with indolent prostate cancer among patients with intermediate risk disease. Results from a large, multi-institutional series

55. Carbon Dioxide Emissions along the Lower Amazon River

56. Growth deficits in cystic fibrosis mice begin in utero prior to IGF-1 reduction.

57. Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study

58. The first 100 cases of COVID-19 in a Hospital in Madrid with a 2-month follow-up

59. Unilateral pelvic lymph node dissection in prostate cancer patients diagnosed in the era of MRI-targeted biopsy: A study that challenges the dogma

60. Who is the right patient for salvage radical prostatectomy? oncological outcomes compared between EAU guidelines-compliant and non-compliant patients

61. Definition and predictors of upgrading at final pathology in prostate cancer patients undergoing MRI-targeted and systematic biopsies: results from a large, multi-institutional series

64. The benefit of adopting Microultrasound in the prostate cancer imaging pathway : A lesion-by-lesion analysis

65. Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups

66. Human capital dynamics in China: Evidence from a club convergence approach

67. An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer

68. Prostate cancer detection rate of repeated biopsy in patients with positive mpMRI and negative initial target and random biopsy. An EAU-YAU Prostate Cancer Working Group multi-institutional study

72. A BAC Transgene Expressing Human CFTR under Control of Its Regulatory Elements Rescues Cftr Knockout Mice

73. Outcomes of prostate cancer patients with seminal vesicle invasion at multiparametric MRI managed with radical prostatectomy. Do all patients really need for a multi-modal approach?

74. The prognostic value of the number of positive targeted cores in men with positive multiparametric magnetic resonance imaging of the prostate. results from a large, multi-institutional series

76. Added value of mpmri in the stratification of patients with high-risk patients prostate cancer treated with radical prostatectomy: implications for tailored multi-modal strategies

77. PD57-08 INDIVIDUALIZED RISK STRATICATION OF PATIENTS CANDIDATE TO RADICAL PROSTATECTOMY BASED ON CLINICAL AND MULTI-PARAMETRIC MRI PARAMETERS: BEYOND THE CONVENTIONAL CLINICAL RISK MODELS

78. Definition and predictors of upgrading at final pathology in prostate cancer patients undergoing mri-targeted and systematic biopsies: Results from a large, multi-institutional series

79. The prognostic value of the number of positive targeted cores in men with positive multiparametric magnetic resonance imaging of the prostate. Results from a large, multi-institutional series

80. Prostate cancers detected at multi-parametric MRI targeted versus systematic biopsies: are they equal? Results from a large multi-institutional series

82. Development and external validation of a novel tool predicting lymph node invasion in patients with prostate cancer detected at targeted-biopsies

83. Improving bench design through discrete fracture network analysis

84. Infective endocarditis in patients with solid organ transplantation. A nationwide study

85. Implementación de módulo didáctico para el estudio del funcionamiento de los sistemas fototérmicos y fotovoltaicos

86. External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection

87. Second generation of temporary implantable nitinol device (iTind) in men with lower urinary tract symptoms (LUTS): Who profit most from treatment? 2 year results of the MT-02-study

88. When is mp-MRI reliable in predicting extra-prostatic extension in prostate cancer patients treated with radical prostatectomy? Results from a large, multi-institutional series

89. The added value of concomitant systematic biopsy in predicting biochemical recurrence after radical prostatectomy in patients with prostate cancer diagnosed by MRI-targeted biopsy

90. Heterogeneous determinants of educational achievement and inequality across urban China

91. Is biofilm production a prognostic marker in adults with candidaemia?

92. Exogenous CXCL4 infusion inhibits macrophage phagocytosis by limiting CD36 signalling to enhance post-myocardial infarction cardiac dilation and mortality

93. Individualized risk stratification of patients candidate to radical prostatectomy based on clinical and multi-parametric MRI parameters: Beyond the conventional clinical risk models

94. Added value of radiological tumor stage in predicting early oncological outcomes in prostate cancer patients undergoing radical prostatectomy within clinical stage: A stage-by-stage analysis

95. Cancer control outcomes following focal therapy using HIFU in 1,829 men with non-metastatic prostate cancer treated over 15 years

96. An algorithm to personalize nerve sparing in men with unilateral high-risk prostate cancer

98. No evidence of increased ocular involvement in candidemic patients initially treated with echinocandins

99. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy

100. Fusionsbiopsie der Prostata liefert zuverlässige Ergebnisse

Catalog

Books, media, physical & digital resources